je.st
news
Investor delighted to support cancer drug project
2015-07-23 14:13:36| Biotech - Topix.net
FUND manager Woodford Investment Management, based in Oxford, is one of several new investors in Immunocure as a result of the biotechnology firm's A 205m private financing round. The company said it would use the proceeds to accelerate its pipeline of biological drugs, which it calls ImmTACs, and which the biotech firm believes have the potential to treat solid cancer tumours.
Tags: support
project
drug
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||